SAFT vs SAFE vs Token Warrant: Choosing the Instrument

A Token Warrant layers a separate token right on top of an equity investment. Each encodes a different legal logic, a different economic bargain, and a different regulatory footprint — and the right choice depends on where the project sits in its development cycle, what the investors actually need, and what counsel reads in the regulatory environment at signing.

The three sit against the same criteria here: mechanics, regulatory hook, investor profile, and fit. The job is to locate the decision, not to restack the definitions.

‍

Why These Three Instruments Exist and How They Diverged

All three share a common ancestor in the Y Combinator SAFE, designed in 2013 to defer the valuation question until a later priced round. The SAFT Project (Cooley/Protocol Labs, 2017) adapted that deferral logic to token projects, replacing "equity at a future priced round" with "tokens at a Token Generation Event." Token Warrants then emerged as a structural response to the SEC's enforcement posture after the Telegram and Kik cases, attempting to disaggregate the equity investment from the token allocation — and restore optionality that a SAFT's delivery obligation removes.

Each evolution was driven by counsel trying to find structures that could survive regulatory scrutiny. None of them is a safe harbour. SEC Release 33-11412 (effective 23 March 2026), which superseded the 2019 Staff Framework, confirmed that the Howey analysis follows the facts at each point in time: at signing, at TGE, at warrant exercise. The name on the document does not determine the legal outcome; the economics and the investor's reasonable expectations do.

‍

The SAFT: What It Is, What It Promises, and Where It Fits

A Simple Agreement for Future Tokens is a forward contract. The investor pays money now in exchange for a contractual right to receive tokens at a future Token Generation Event. The SAFT does not give the investor equity in the issuer company. It gives a claim to tokens at a discount to the anticipated public price or on a pre-agreed allocation formula, typically with a deadline by which the TGE must occur. The original SAFT Project template also included pro-rata participation rights for future token rounds, though specific terms vary considerably across templates in use today.

The investor holds no governance rights in the company, no board seat rights, and no equity dilution protection. The SAFT is a contract for future delivery of a commodity or security, depending on what the tokens look like at delivery.

The SAFT's Regulatory Position

The SAFT was designed on the premise that tokens delivered at TGE would be functional utility tokens no longer satisfying Howey. The Telegram and Kik enforcement actions challenged that directly: courts found that the investment-contract analysis applied to the entire scheme, including token delivery, because investors' returns depended on the issuer's efforts. SEC Release 33-11412 did not rescue the original SAFT theory. It provides a framework for time-point analysis but does not create a SAFT-specific exemption. In current practice, a SAFT is offered under Reg D Rule 506(c), restricted to accredited investors, and counsel prepares a separate token classification opinion at or before TGE — not just at signing.

For EU-facing rounds, a SAFT-style pre-sale where the investor's primary right is to receive tokens may constitute an offer to the public under MiCA Arts 4–5 if the tokens fall within MiCA scope and the issuer targets EU persons. This is a pre-issuance obligation the SAFE structure avoids entirely.

Who Invests Through a SAFT

The SAFT is familiar to institutional crypto funds, family offices active in token rounds, and strategic infrastructure investors. These participants understand token economics, model returns on TGE price appreciation, and accept that token delivery is the primary return mechanism. Equity is incidental or irrelevant to their position. Retail investors are not the SAFT's audience: Reg D restricts US participation to accredited investors, and most non-US equivalents impose similar qualified-investor thresholds.

When the SAFT Fits and When It Fails

A SAFT fits when the TGE timeline is near-term and credible, the token utility thesis has been documented by counsel, the entire investor base qualifies as accredited or institutional, and the founders want to keep the company equity clean for future venture rounds without giving token investors equity dilution rights. It fits when the project operates under a Reg D framework and can manage the Howey opinion work at TGE.

The SAFT fails when the TGE timeline is uncertain or indefinite, because a stale delivery obligation becomes a legal and commercial liability. It fails when the token classification is contested, because delivering tokens into an uncertain regulatory status is what the post-Telegram case law penalises. It fails for projects with EU-facing investor bases where MiCA pre-issuance compliance is not yet in place.

‍

The SAFE: Equity-First, No Token Commitment

A Simple Agreement for Future Equity is a Y Combinator instrument (2013, revised in post-money form in 2018). It is an equity instrument. The investor pays money now and receives the right to convert into equity at a future priced qualifying round, on the better of a discount rate or a valuation cap. There is no interest, no maturity date, and no debt repayment obligation. Conversion is automatic at the qualifying financing.

A SAFE has no token mechanics. It does not promise tokens, does not create a forward delivery obligation, and does not give the investor any right to receive tokens. Projects that issue SAFEs are telling investors that the primary return path is through equity — acquisition, secondary transaction, or public listing — not through a TGE.

The SAFE's Regulatory Position

Howey does not apply to the SAFE as a token instrument, because the SAFE does not involve tokens. The SAFE is an investment contract in the traditional securities sense — the investor acquires a right to future equity, which is a security subject to registration or exemption requirements (Reg D in the US, equivalent private placement regimes elsewhere). No additional crypto-specific securities analysis is required for the SAFE itself, though any tokens the company later issues will require their own analysis.

For EU-facing rounds, a SAFE does not trigger MiCA pre-issuance obligations on the token side, because it transfers equity rights in the issuer entity — a company-law matter, not a token issuance. Projects that raise on SAFEs before MiCA compliance documentation is complete are not in violation of MiCA token rules at that stage; the obligation arises when tokens are offered to EU persons.

Who Invests Through a SAFE

Equity investors — venture capital funds, angel investors focused on company value rather than token speculation, and strategic partners seeking board rights — are the SAFE's natural audience. A pre-seed or seed-stage project building a product that may or may not eventually include a token can raise on SAFEs without making a commitment that creates exposure if token plans change. Investors in the US, Singapore, and UAE markets accept the YC post-money SAFE as a standard instrument with well-understood mechanics; cross-border investors may require adaptation for local securities and insolvency rules.

When the SAFE Fits and When It Fails

The SAFE fits when the investor relationship is primarily about company equity value, when no token commitment is appropriate at the current stage, and when the founders want to preserve optionality — including the option never to issue a token. It fits for equity-focused investors who want governance rights a SAFT cannot deliver.

The SAFE fails when investors specifically want token exposure. A crypto fund that models returns on token allocation and TGE price appreciation will find the SAFE structurally unsuitable, because the SAFE delivers equity, not tokens. Using a SAFE where investors commercially expect token participation — without a Token Warrant alongside it — creates a mismatch that typically surfaces at TGE.

‍

The Token Warrant: Bifurcating Equity and Token Rights

A Token Warrant is not a standalone fundraising instrument in the way a SAFE or SAFT is. It is a derivative document — signed alongside a SAFE or a priced equity round — that gives the investor the right, but not the obligation, to purchase a quantity of tokens at TGE at a pre-agreed exercise price. The equity investment and the token right are documented separately, governed separately, and exercisable independently.

The core economic structure: the investor receives a SAFE on standard terms, plus a Token Warrant specifying the token quantity or allocation formula, the exercise price, the exercise window (typically a period starting at TGE), and what happens if no TGE occurs within a specified period. Norton Rose Fulbright's Venture Capital Series (live as of 24 August 2026) describes Token Warrants as instruments giving the holder the right, but typically not the obligation, to purchase tokens — a characterisation the SEC's CoinList comment letter (9 July 2025) confirms. If the TGE does not happen or the token performs poorly, the equity position under the SAFE is unaffected.

The Token Warrant's Regulatory Logic

The structural argument for the Token Warrant is that it disaggregates the Howey analysis across two separate instruments. The SAFE involves standard equity securities analysis. The Token Warrant is exercised at TGE, when — under SEC Release 33-11412's time-point framework — the token's regulatory status can be assessed on current facts. If the token, at the moment of warrant exercise, has achieved the characteristics the Release associates with non-securities status (functional utility, decentralised control, no ongoing issuer-driven profit expectation), the exercise may occur outside the investment-contract framework.

Academic support for this argument appears in the George Washington Business & Finance Law Review (Quatrella, Vol. 7(2), 2024), examining specifically how the SAFE + Token Warrant reduces Howey exposure versus a SAFT. Orrick and Norton Rose Fulbright practitioner notes reflect the same logic. None of these are safe harbours. Counsel will want the same point-in-time Howey analysis at warrant exercise that a SAFT requires at TGE. The difference is that if the analysis does not resolve cleanly, the warrant can lapse without affecting the equity position — a risk-management option the SAFT does not offer.

Who Invests Through a Token Warrant

Investors who want both equity alignment and token optionality use the Token Warrant. Equity-first venture funds that have historically invested on SAFEs but want TGE upside without pure token delivery risk fit this profile. Strategic investors — launchpads, exchanges, ecosystem funds — that need equity governance rights but also expect token allocation as part of the commercial relationship are another natural audience. Founders who want equity-committed investors, rather than token-only speculators, also tend to prefer the Token Warrant structure.

When the Token Warrant Fits and When It Fails

The Token Warrant fits when the TGE timeline is uncertain and locking in a SAFT delivery obligation would create commercial and legal risk. It fits when the token classification is unresolved and counsel advises against a direct token sale until the analysis is complete. It fits for sophisticated institutional investors who are comfortable with two-document structures and can conduct their own Howey assessment at the time of warrant exercise.

The Token Warrant fails for investors who want guaranteed token allocation rather than an option. A crypto fund that contractually needs specific token quantities at TGE — and has modelled the investment on receiving those tokens — will not accept a warrant that can lapse. The structure also creates complexity when the issuer operates across jurisdictions where the warrant itself may be characterised differently under local securities or insolvency rules.

‍

What SEC Release 33-11412 Changes for Instrument Selection

Release 33-11412 (effective 23 March 2026) sharpened the time-point Howey analysis without creating new safe harbours. For SAFTs, it reinforces that token delivery into a still-centralised network faces Howey scrutiny at the delivery date, not just at signing. For SAFEs, it is largely irrelevant to the equity instrument itself. For Token Warrants, it provides the analytical window practitioners cite: if the network, at the time of warrant exercise, has achieved functional decentralisation and the holder's returns no longer depend primarily on issuer effort, the exercise may occur outside the investment-contract framework. The Release does not guarantee that outcome — it provides the structure counsel uses to get there. Confirm the analysis with US securities counsel for your specific token and TGE structure.

‍

How MiCA Affects the Choice for EU-Facing Rounds

A SAFT-style pre-sale to EU persons — where the investor's primary right is to receive tokens — may trigger MiCA's offer-to-the-public requirements under Arts 4–5 if the tokens fall within MiCA's scope. The issuer must then publish a white paper and, for asset-referenced tokens, obtain authorisation before offering. A SAFE does not create this pre-issuance exposure because it transfers equity rights in the issuer entity, not token rights. A SAFE + Token Warrant structure separates the equity transfer (outside MiCA's token scope at signing) from the token allocation (exercised at TGE, after MiCA compliance is complete). Whether the token warrant itself constitutes a crypto-asset under MiCA's definitions is fact-specific; confirm with EU-qualified counsel. The Medici Expert article on what MiCA means for every company covers the broader framework.

‍

VARA's Rulebook and UAE-Nexus Projects

Projects with UAE nexus — issuer entity, investor base, or token distribution — must map the token issuance against VARA's Virtual Asset Issuance Rulebook (effective 19 June 2025). VARA distinguishes categories of virtual assets with different whitepaper requirements and licensing obligations. A SAFT creates a delivery obligation that counsel must map against VARA's distribution rules before signing. A SAFE with a Token Warrant can defer that mapping to TGE, when the issuer's VARA compliance posture is clearer. Medici Expert's digital assets practice covers UAE token structuring analysis, from issuer entity selection through VARA whitepaper documentation.

‍

Tax Treatment: Where the Three Instruments Diverge

Tax treatment differs meaningfully across all three instruments. The following reflects US federal tax considerations as of August 2026 and is not tax advice; engage US tax counsel before signing any of these instruments.

A SAFE held by an investor is generally treated as a financial instrument converting to equity. Under emerging consensus following IRS Notice 2023-2, a post-money SAFE converts to equity at the qualifying financing without triggering ordinary income recognition at conversion. The investor's primary tax event is the eventual equity sale.

Token delivery under a SAFT is treated as the investor receiving property. Under IRS Notice 2014-21 and Rev. Rul. 2023-14, tokens received at TGE are property valued at fair market value on the delivery date — potentially ordinary income, with a cost basis equal to the amount recognised. If the token price at delivery substantially exceeds the SAFT investment price, the income recognised at TGE can be material; investors should model this scenario before committing.

The Token Warrant's equity component follows equity tax rules. The warrant itself, at issuance, typically has no immediate tax consequence. When the investor exercises the warrant at TGE — paying the exercise price and receiving tokens — the spread between exercise price and fair market value at exercise is likely ordinary income in that year. A lapsed warrant produces a capital loss. Founders structuring tokenomics should consider how token FMV at TGE affects investor behaviour post-exercise.

‍

What Counsel Checks Before a SAFT Is Signed

Counsel wants a near-term, credible TGE timeline; a documented token utility thesis supporting a Howey opinion at delivery; an accredited-investor-only structure under Reg D 506(c) or a non-US equivalent; and no existing regulatory entanglements at the issuer entity. If EU persons are in scope, the MiCA analysis becomes a precondition. If the token classification is unresolved or the TGE depends on genuinely uncertain events, counsel will typically recommend against a SAFT — the delivery obligation creates legal exposure in both directions.

‍

What Counsel Checks Before a SAFE Is Issued

Counsel recommends a SAFE when the equity-first logic is authentic: investors understand their return path is through equity, not token allocation. If investors commercially expect tokens and founders intend to issue them, a SAFE without a Token Warrant creates a mismatch that typically surfaces at TGE. Counsel also reviews whether the YC post-money SAFE is enforceable under local law for non-US investors in the round — the instrument is US-designed, and its treatment under UAE, Singapore, or EU insolvency and securities rules requires separate review.

‍

What Counsel Checks Before a Token Warrant Is Issued

Counsel looks for two-document consistency: the SAFE and the Token Warrant must align on definitions of the issuer entity, the token type, and the TGE trigger event. Warrant terms — exercise price, exercise window, anti-dilution, pro-rata — require the same negotiation rigour as SAFE terms. Counsel also reviews whether the Token Warrant itself, in the issuer's relevant jurisdictions, could be characterised as a security at signing, requiring its own exemption or registration. For projects structuring entity and licensing strategy across multiple jurisdictions, the Token Warrant's flexibility on TGE timing can be a meaningful structural advantage over a SAFT that locks in delivery obligations to all investors at once.

‍

Which Profile Points to Which Instrument

Three recognisable project profiles correspond to the three instruments. Matching the profile to the project is where the instrument choice typically begins.

A project raising its first institutional round at seed stage — working product, equity-focused venture investors, token plans genuinely undecided — reaches for the SAFE. The equity relationship is primary; the SAFE avoids premature token commitments and keeps the round simple.

A project with a defined token economy, a near-term TGE, and an institutional investor base of crypto funds modelling token returns reaches for the SAFT — provided counsel has completed the Howey analysis and the Reg D mechanics are in place. Token delivery is the point of the investment; equity is incidental.

A project that has raised equity on a SAFE or priced round and wants to give those investors TGE access — without reopening the equity round and without committing to a SAFT delivery obligation before the token classification is settled — reaches for the Token Warrant. The warrant gives investors an election, not an obligation, and preserves the equity structure already in place.

‍

FAQ

Is a SAFE the same as a SAFT?

No. A SAFE — Simple Agreement for Future Equity — converts into company shares at a future priced round. It is an equity instrument with no token mechanics. A SAFT — Simple Agreement for Future Tokens — converts into tokens at a Token Generation Event. They share a structural ancestor in the Y Combinator SAFE, but operate in different legal frameworks: a SAFE involves standard company-law and securities analysis; a SAFT adds Howey analysis at token delivery. Confusing the two leads to investors receiving equity when they expected tokens, or founders facing securities exposure they did not anticipate.

What is a Token Warrant and how does it differ from a SAFT?

A Token Warrant is a derivative right — issued alongside a SAFE or priced equity round — that gives the holder the option to purchase tokens at TGE at a pre-agreed price. A SAFT is a standalone forward contract obligating the issuer to deliver tokens at TGE. The practical difference is that a Token Warrant can lapse if the TGE does not occur or if the investor elects not to exercise; a SAFT creates a bilateral delivery obligation that cannot lapse unilaterally. Norton Rose Fulbright and Orrick practitioner notes both describe the warrant's option character as its defining structural feature.

Does SEC Release 33-11412 change which instrument I should use?

The Release (effective 23 March 2026) confirmed that Howey applies at each relevant point in time and that a token can move in and out of securities status as the network's facts change. It does not create a safe harbour for any of the three instruments. For SAFTs, it reinforces that delivery into a still-centralised network faces Howey at that date. For Token Warrants, it provides the analytical framework for arguing that warrant exercise — when the network may have achieved functional decentralisation — can be assessed on the token's current facts rather than on the facts at the original investment date. Confirm the analysis with US securities counsel for your specific token and TGE structure.

Can I issue a SAFE to EU investors without triggering MiCA?

A SAFE transfers equity rights in the issuer entity, not token rights, and does not directly trigger MiCA pre-issuance obligations. When the project later issues tokens to EU persons, MiCA's white paper and notification requirements apply at that stage. A SAFT-style pre-sale to EU investors — where the primary right is to receive tokens — creates MiCA exposure that the SAFE avoids. A SAFE + Token Warrant structure can separate the equity transfer from the token allocation, with the warrant exercised only at TGE after MiCA compliance is in place. Whether the warrant itself constitutes a crypto-asset under MiCA's definitions is fact-specific; confirm with EU-qualified counsel.

What are the main US tax differences between these three instruments?

A SAFE typically converts to equity without triggering ordinary income recognition at conversion; the investor's tax event is the later equity sale. A SAFT investor generally recognises income at TGE when tokens are delivered, at fair market value on the delivery date — potentially ordinary income under the IRS property framework. A Token Warrant investor recognises income at exercise, when the spread between the exercise price and the token's fair market value at exercise is likely ordinary income. All three carry complexity; the treatment depends on the investor's specific circumstances and evolving IRS guidance. Engage US tax counsel before signing any of these instruments.

When should a project issue a SAFT rather than a Token Warrant?

A SAFT is appropriate when the TGE timeline is near-term and credible, the token classification has been analysed and documented by counsel, all investors are accredited or institutional, and investors specifically want guaranteed token allocation rather than an option. Institutional crypto funds that model returns on specific token quantities at TGE — and need those tokens as a contractual matter — often prefer the SAFT's certainty to the Token Warrant's optionality. The SAFT is the higher-commitment instrument; use it when the commitment is genuinely supportable on the facts.

What happens if I raise on SAFTs and then cannot deliver tokens on time?

Late or failed token delivery gives investors contractual remedies: typically a right to refund, extension negotiation, or conversion at a revised formula. If the delay stems from a regulatory obstacle — unresolved token classification, for example — the issuer may face both contractual claims and regulatory exposure if the SAFT is later found to have been an unregistered securities offering. SAFTs with vague or indefinite TGE triggers are a common source of disputes. Counsel should define the TGE event and the failure remedy precisely before the SAFT is signed.

Do I need separate legal opinions for the SAFT and the token delivery?

Generally, yes. The SAFT itself — as the security being sold to accredited investors — typically requires a Reg D offering opinion or memorandum confirming the exemption and the investor qualification process. The token delivery at TGE requires a separate token classification opinion assessing whether the tokens, at the time of delivery, satisfy Howey. These are two distinct legal questions answered at two different points in time. For a Token Warrant, the warrant itself may require a similar analysis at issuance, and the token analysis at exercise mirrors the TGE analysis for a SAFT. See Medici Expert's digital assets practice for how token structuring, classification, and fundraising documentation are assembled as one legal package.

Sources

• Y Combinator SAFE (Post-Money, 2018): https://www.ycombinator.com/documents
• The SAFT Project White Paper (Cooley/Protocol Labs, 2017): https://saftproject.com
• SEC Release Nos. 33-11412 / 34-105020, effective 23 March 2026: https://www.sec.gov/files/rules/interp/2026/33-11412.pdf
• SEC, CoinList Comment Letter to Crypto Task Force, 9 July 2025: https://www.sec.gov/files/ctf-written-input-coinlist-070925.pdf
• Norton Rose Fulbright, Venture Capital Series — Token Issuances and Warrants: https://www.nortonrosefulbright.com/en/knowledge/publications/07e1603b/venture-capital-series-article-4-token-issuances-and-warrants
• Orrick, "5 Things to Know About Token Warrants": https://blogs.orrick.com/blockchain/5-things-to-know-about-token-warrants/
• Quatrella, D., "SAFE and Sound? Examining How the SAFE + Token Warrant Structure Reduces Howey Exposure," GWU Business & Finance Law Review, Vol. 7(2) (2024): https://gwbflr.org/wp-content/uploads/2024/05/V7I2-Article-4.pdf
• Astraea Counsel, "Crypto Venture Capital Fundraising: SAFE vs SAFT Guide," 22 June 2026: https://astraea.law/insights/crypto-venture-capital-fundraising-guide
• Promise Legal, "SAFT vs. SAFE: How Pre-Token Funding Works," 7 July 2026: https://blog.promise.legal/saft-vs-safe-web3-pre-token-funding/
• MiCA Regulation (EU) 2023/1114, Arts 4–9: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02023R1114-20240109
• VARA Virtual Asset Issuance Rulebook, effective 19 June 2025: https://rulebooks.vara.ae
• IRS Notice 2014-21: https://www.irs.gov/irb/2014-16_IRB#NOT-2014-21
• Rev. Rul. 2023-14: https://www.irs.gov/pub/irs-drop/rr-23-14.pdf
• Medici Expert insights on MiCA: https://medici.expert/insights/what-mica-means-for-every-company
• Medici Expert insights on crypto compliance: https://medici.expert/insights/building-real-rules-for-crypto